These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36171475)

  • 21. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
    Matos AR; Resende PC; Miranda MD; Garcia CC; Caetano BC; Lopes JCO; Debur MC; Cury ALF; Vianna LA; Lima MC; Schirmer M; Gubareva L; Hurt AC; Brown DW; Siqueira MM
    Antiviral Res; 2018 Jun; 154():35-43. PubMed ID: 29601892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant Variants.
    Pascua PNQ; Jones JC; Marathe BM; Seiler P; Caufield WV; Freeman BB; Webby RJ; Govorkova EA
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0113721. PubMed ID: 34424039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
    Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
    Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
    Govorkova EA; Takashita E; Daniels RS; Fujisaki S; Presser LD; Patel MC; Huang W; Lackenby A; Nguyen HT; Pereyaslov D; Rattigan A; Brown SK; Samaan M; Subbarao K; Wong S; Wang D; Webby RJ; Yen HL; Zhang W; Meijer A; Gubareva LV
    Antiviral Res; 2022 Apr; 200():105281. PubMed ID: 35292289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.
    Seibert CW; Kaminski M; Philipp J; Rubbenstroth D; Albrecht RA; Schwalm F; Stertz S; Medina RA; Kochs G; García-Sastre A; Staeheli P; Palese P
    J Virol; 2010 Nov; 84(21):11219-26. PubMed ID: 20739532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.
    Kim HM; Lee N; Kim MS; Kang C; Chung YS
    Virol J; 2020 Jul; 17(1):94. PubMed ID: 32631440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
    J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replicative Fitness of Seasonal Influenza A Viruses With Decreased Susceptibility to Baloxavir.
    Chesnokov A; Patel MC; Mishin VP; De La Cruz JA; Lollis L; Nguyen HT; Dugan V; Wentworth DE; Gubareva LV
    J Infect Dis; 2020 Jan; 221(3):367-371. PubMed ID: 31541547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.
    Takashita E; Fujisaki S; Kishida N; Xu H; Imai M; Tashiro M; Odagiri T;
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1390-9. PubMed ID: 23745712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
    Pascua PN; Marathe BM; Burnham AJ; Vogel P; Webby RJ; Webster RG; Govorkova EA
    PLoS One; 2016; 11(7):e0159847. PubMed ID: 27466813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
    Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
    Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favipiravir-resistant influenza A virus shows potential for transmission.
    Goldhill DH; Yan A; Frise R; Zhou J; Shelley J; Gallego Cortés A; Miah S; Akinbami O; Galiano M; Zambon M; Lackenby A; Barclay WS
    PLoS Pathog; 2021 Jun; 17(6):e1008937. PubMed ID: 34061908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
    Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
    PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
    Hamelin ME; Baz M; Abed Y; Couture C; Joubert P; Beaulieu E; Bellerose N; Plante M; Mallett C; Schumer G; Kobinger GP; Boivin G
    PLoS Pathog; 2010 Jul; 6(7):e1001015. PubMed ID: 20661429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
    Lee LY; Zhou J; Koszalka P; Frise R; Farrukee R; Baba K; Miah S; Shishido T; Galiano M; Hashimoto T; Omoto S; Uehara T; Mifsud EJ; Collinson N; Kuhlbusch K; Clinch B; Wildum S; Barclay WS; Hurt AC
    PLoS Pathog; 2021 May; 17(5):e1009527. PubMed ID: 33956888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.